Similar articles

• The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents.

  Plaut M, Marone G, Gillespie E. Plaut M, et al. J Immunol. 1983 Dec;131(6):2945-52. J Immunol. 1983. PMID: 6315818
• Increased responsiveness to adenosine 3'5'-cyclic monophosphate-active agents during the immune response in vivo.

  Plaut M. Plaut M. Immunopharmacology. 1981 Jun;3(2):107-16. doi: 10.1016/0162-3109(81)90012-6. Immunopharmacology. 1981. PMID: 6265406
• Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones.

  Melmon KL, Bourne HR, Weinstein Y, Shearer GM, Kram J, Bauminger S. Melmon KL, et al. J Clin Invest. 1974 Jan;53(1):13-21. doi: 10.1172/JCI107530. J Clin Invest. 1974. PMID: 4357609 Free PMC article.
• The role of cyclic nucleotides in the cell cycle.

  Friedman DL, Johnson RA, Zeilig CE. Friedman DL, et al. Adv Cyclic Nucleotide Res. 1976;7:69-114. Adv Cyclic Nucleotide Res. 1976. PMID: 188318 Review. No abstract available.
• The role of cyclic nucleotides in lymphocyte activation and function.

  Strom TB, Lundin AP, Carpenter CB. Strom TB, et al. Prog Clin Immunol. 1977;3:115-53. Prog Clin Immunol. 1977. PMID: 194278 Review. No abstract available.